TY - JOUR AU - Ter-Pogossian, M. M. AU - Phelps, M. E. AU - Hoffman, E. J. AU - Mullani, N. A. PY - 1975 DA - 1975// TI - A positron-emission transaxial tomograph for nuclearimaging (PETT) JO - Radiology. VL - 114 UR - https://doi.org/10.1148/114.1.89 DO - 10.1148/114.1.89 ID - Ter-Pogossian1975 ER - TY - JOUR AU - Phelps, M. E. AU - Hoffman, E. J. AU - Mullani, N. A. AU - Ter-Pogossian, M. M. PY - 1975 DA - 1975// TI - Application of annihilation coincidence detection totransaxial reconstruction tomography JO - J Nucl Med VL - 16 ID - Phelps1975 ER - TY - JOUR AU - Schöder, H. AU - Erdi, Y. E. AU - Larson, S. M. AU - Yeung, H. W. PY - 2003 DA - 2003// TI - PET/CT: a new imaging technology in nuclearmedicine JO - Eur J Nucl Med Mol Imaging VL - 30 ID - Schöder2003 ER - TY - JOUR AU - Halldin, C. AU - Gulyas, B. AU - Langer, O. AU - Farde, L. PY - 2001 DA - 2001// TI - Brain radioligands--state of the art and newtrends JO - Quart J Nucl Med Mol Imaging VL - 45 ID - Halldin2001 ER - TY - STD TI - Phelps ME. PET: molecular imaging and its biological applications:Springer Science & Business Media; 2004. ID - ref5 ER - TY - JOUR AU - Phelps, M. E. PY - 2000 DA - 2000// TI - PET: the merging of biology and imaging intomolecular imaging JO - J Nucl Med VL - 41 ID - Phelps2000 ER - TY - JOUR AU - Herschman, H. R. PY - 2003 DA - 2003// TI - Micro-PET imaging and small animal models ofdisease JO - Curr Opin Immunol VL - 15 UR - https://doi.org/10.1016/s0952-7915(03)00066-9 DO - 10.1016/s0952-7915(03)00066-9 ID - Herschman2003 ER - TY - JOUR AU - Pike, V. W. PY - 2009 DA - 2009// TI - PET radiotracers: crossing the blood–brain barrierand surviving metabolism JO - Trends Pharmacol Sci VL - 30 ID - Pike2009 ER - TY - JOUR AU - Bittner, G. C. AU - Ricq, E. L. AU - Hooker, J. M. PY - 2014 DA - 2014// TI - A philosophy for CNS radiotracerdesign JO - Acc Chem Res VL - 47 UR - https://doi.org/10.1021/ar500233s DO - 10.1021/ar500233s ID - Bittner2014 ER - TY - JOUR AU - Halldin, C. AU - Gulyas, B. AU - Farde, L. PY - 2001 DA - 2001// TI - PET studies with carbon-11 radioligands inneuropsychopharmacological drug development JO - Curr Pharm Des VL - 7 UR - https://doi.org/10.2174/1381612013396871 DO - 10.2174/1381612013396871 ID - Halldin2001 ER - TY - STD TI - Comar D. PET for drug development and evaluation: Springer Science& Business Media; 2012. ID - ref11 ER - TY - JOUR AU - Price, J. C. AU - Lopresti, B. J. AU - Meltzer, C. C. AU - Smith, G. S. AU - Mason, N. S. AU - Huang, Y. PY - 2001 DA - 2001// TI - Analyses of [18F] altanserin bolus injection PETdata. II: consideration of radiolabeled metabolites in humans JO - Synapse. VL - 41 ID - Price2001 ER - TY - BOOK AU - Williams, R. T. PY - 1959 DA - 1959// TI - Detoxication mechanisms: the metabolism and detoxication of drugs,toxic substances, and other organic compounds: Wiley ID - Williams1959 ER - TY - BOOK AU - Silverman, R. B. PY - 1995 DA - 1995// TI - Medizinische Chemie für Organiker, Biochemiker und PharmazeutischeChemiker ID - Silverman1995 ER - TY - STD TI - Petrides GLaPE. Biochemie und Pathobiochemie: Springer;1998. ID - ref15 ER - TY - JOUR AU - Fischman, A. J. AU - Alpert, N. M. AU - Rubin, R. H. PY - 2002 DA - 2002// TI - Pharmacokinetic imaging: a noninvasive method fordetermining drug distribution and action JO - Clin Pharmacokinet VL - 41 UR - https://doi.org/10.2165/00003088-200241080-00003 DO - 10.2165/00003088-200241080-00003 ID - Fischman2002 ER - TY - JOUR AU - Hammond, L. A. AU - Denis, L. AU - Salman, U. AU - Jerabek, P. AU - Thomas, C. R. AU - Kuhn, J. G. PY - 2003 DA - 2003// TI - Positron emission tomography (PET): expanding thehorizons of oncology drug development JO - Investig New Drugs VL - 21 UR - https://doi.org/10.1023/a:1025468611547 DO - 10.1023/a:1025468611547 ID - Hammond2003 ER - TY - JOUR AU - Wolff, M. E. PY - 1996 DA - 1996// TI - Burger’s medicinal chemistry and drugdiscovery JO - Am J Ther VL - 3 ID - Wolff1996 ER - TY - STD TI - Mazière B, Cantineau R, Coenen HH, Guillaume M, Halldin C, Luxen A,et al. PET radiopharmaceutical metabolism—plasma metabolite analysis.Radiopharmaceuticals for positron emission tomography: Springer; 1993. p.151–78. ID - ref19 ER - TY - JOUR AU - Frullano, L. AU - Catana, C. AU - Benner, T. AU - Sherry, A. D. AU - Caravan, P. PY - 2010 DA - 2010// TI - Bimodal MR–PET agent for quantitative pHimaging JO - Angew Chem VL - 122 ID - Frullano2010 ER - TY - JOUR AU - Southworth, R. AU - Parry, C. R. AU - Parkes, H. G. AU - Medina, R. A. AU - Garlick, P. B. PY - 2003 DA - 2003// TI - Tissue-specific differences in2-fluoro-2-deoxyglucose metabolism beyond FDG-6-P: a 19F NMR spectroscopystudy in the rat JO - NMR Biomed VL - 16 UR - https://doi.org/10.1002/nbm.856 DO - 10.1002/nbm.856 ID - Southworth2003 ER - TY - JOUR AU - Osman, S. AU - Lundkvist, C. AU - Pike, V. W. AU - Halldin, C. AU - McCarron, J. A. AU - Swahn, C. -. G. PY - 1996 DA - 1996// TI - Characterization of the radioactive metabolites ofthe 5-HT1A receptor radioligand,[O-methl-11C] WAY-100635, in monkey andhuman plasma by HPLC: comparison of the behaviour of an identifiedradioactive metabolite with parent radioligand in monkey usingPET JO - Nucl Med Biol VL - 23 ID - Osman1996 ER - TY - JOUR AU - Osman, S. AU - Lundkvist, C. AU - Pike, V. W. AU - Halldin, C. AU - McCarron, J. A. AU - Swahn, C. -. G. PY - 1998 DA - 1998// TI - Characterisation of the appearance of radioactivemetabolites in monkey and human plasma from the 5-HT1A receptorradioligand,[carbonyl-11C] WAY-100635—explanation of high signal contrast inPET and an aid to biomathematical modelling JO - Nucl Med Biol VL - 25 ID - Osman1998 ER - TY - JOUR AU - Nakao, R. AU - Halldin, C. PY - 2013 DA - 2013// TI - A simplified radiometabolite analysis procedure forPET radioligands using a solid phase extraction with micellarmedium JO - Nucl Med Biol VL - 40 ID - Nakao2013 ER - TY - JOUR AU - Moein, M. M. AU - Nakao, R. AU - Amini, N. AU - Abdel-Rehim, M. AU - Schou, M. AU - Halldin, C. PY - 2019 DA - 2019// TI - Sample preparation techniques for radiometaboliteanalysis of positron emission tomography radioligands; trends, progress,limitations and future prospects JO - TrAC Trends Anal Chem VL - 110 ID - Moein2019 ER - TY - JOUR AU - Melega, W. P. AU - Grafton, S. T. AU - Huang, S. C. AU - Satyamurthy, N. AU - Phelps, M. E. AU - Barrio, J. R. PY - 1991 DA - 1991// TI - L-6-[18F]fluoro-dopa metabolism in monkeys andhumans: biochemical parameters for the formulation of tracer kinetic modelswith positron emission tomography JO - J Cereb Blood Flow Metab VL - 11 UR - https://doi.org/10.1038/jcbfm.1991.154 DO - 10.1038/jcbfm.1991.154 ID - Melega1991 ER - TY - STD TI - Carson RE. Tracer kinetic modeling in PET. Positron emissiontomography: Springer; 2005. p. 127–59. ID - ref27 ER - TY - JOUR AU - Ishiwata, K. AU - Itou, T. AU - Ohyama, M. AU - Yamada, T. AU - Mishina, M. AU - Ishii, K. PY - 1998 DA - 1998// TI - Metabolite analysis of [11 C] flumazenil in humanplasma: assessment as the standardized value for quantitative PETstudies JO - Ann Nucl Med VL - 12 ID - Ishiwata1998 ER - TY - JOUR AU - Kalgutkar, A. S. AU - Nguyen, H. T. PY - 2004 DA - 2004// TI - Identification of anN-methyl-4-phenylpyridinium-like metabolite of the antidiarrheal agentloperamide in human liver microsomes: underlying reason(s) for the lack ofneurotoxicity despite the bioactivation event JO - Drug Metab Dispos VL - 32 ID - Kalgutkar2004 ER - TY - JOUR AU - Zoghbi, S. S. AU - Branch, M. I. PY - 2007 DA - 2007// TI - 11 C-Loperamide and its N-desmethyl radiometaboliteare avid substrates for brain P-glycoprotein efflux JO - J Nucl Med VL - 48 ID - Zoghbi2007 ER - TY - JOUR AU - Yoshida, K. AU - Nambu, K. AU - Arakawa, S. AU - Miyazaki, H. AU - Hashimoto, M. PY - 1979 DA - 1979// TI - Metabolites of loperamide in rats JO - Biomed Mass Spectrom VL - 6 UR - https://doi.org/10.1002/bms.1200060606 DO - 10.1002/bms.1200060606 ID - Yoshida1979 ER - TY - JOUR AU - Peyronneau, M. A. AU - Saba, W. AU - Dolle, F. AU - Goutal, S. AU - Coulon, C. AU - Bottlaender, M. PY - 2012 DA - 2012// TI - Difficulties in dopamine transporter radioligand PETanalysis: the example of LBT-999 using [18F] and [11C] labelling: part II:metabolism studies JO - Nucl Med Biol VL - 39 UR - https://doi.org/10.1016/j.nucmedbio.2011.09.006 DO - 10.1016/j.nucmedbio.2011.09.006 ID - Peyronneau2012 ER - TY - JOUR AU - Saba, W. AU - Peyronneau, M. A. AU - Dolle, F. AU - Goutal, S. AU - Bottlaender, M. AU - Valette, H. PY - 2012 DA - 2012// TI - Difficulties in dopamine transporter radioligand PETanalysis: the example of LBT-999 using [18F] and [11C] labelling: part I:PET studies JO - Nucl Med Biol VL - 39 UR - https://doi.org/10.1016/j.nucmedbio.2011.08.003 DO - 10.1016/j.nucmedbio.2011.08.003 ID - Saba2012 ER - TY - JOUR AU - Testa, B. AU - Kramer, S. D. PY - 2006 DA - 2006// TI - The biochemistry of drug metabolism--anintroduction: part 1. Principles and overview JO - Chem Biodivers VL - 3 UR - https://doi.org/10.1002/cbdv.200690111 DO - 10.1002/cbdv.200690111 ID - Testa2006 ER - TY - JOUR AU - Giron, M. C. AU - Portolan, S. AU - Bin, A. AU - Mazzi, U. AU - Cutler, C. S. PY - 2008 DA - 2008// TI - Cytochrome P450 and radiopharmaceuticalmetabolism JO - Q J Nucl Med Mol Imaging VL - 52 ID - Giron2008 ER - TY - JOUR AU - Li, Z. AU - Conti, P. S. PY - 2010 DA - 2010// TI - Radiopharmaceutical chemistry for positron emissiontomography JO - Adv Drug Deliv Rev VL - 62 UR - https://doi.org/10.1016/j.addr.2010.09.007 DO - 10.1016/j.addr.2010.09.007 ID - Li2010 ER - TY - JOUR AU - D'Souza, R. A. AU - Partridge, E. A. AU - Roberts, D. W. AU - Ashton, S. AU - Ryan, A. AU - Patterson, A. B. PY - 2007 DA - 2007// TI - Distribution of radioactivity and metaboliteprofiling in tumour and plasma following intravenous administration of acolchicine derivative (14C-ZD6126) to tumour-bearing mice JO - Xenobiotica. VL - 37 UR - https://doi.org/10.1080/00498250601169824 DO - 10.1080/00498250601169824 ID - D'Souza2007 ER - TY - JOUR AU - Nakao, R. AU - Halldin, C. PY - 2013 DA - 2013// TI - Improved radiometabolite analysis procedure forpositron emission tomography (PET) radioligands using a monolithic columncoupled with direct injection micellar/high submicellar liquidchromatography JO - Talanta. VL - 113 ID - Nakao2013 ER - TY - JOUR AU - Buchholz, M. AU - Spahn, I. AU - Coenen, H. H. PY - 2015 DA - 2015// TI - Optimized separation procedure for production ofno-carrier-added radiomanganese for positron emissiontomography JO - Radiochim Acta VL - 103 ID - Buchholz2015 ER - TY - JOUR AU - Pawelke, B. PY - 2005 DA - 2005// TI - Metabolite analysis in positron emission tomographystudies: examples from food sciences JO - Amino Acids VL - 29 UR - https://doi.org/10.1007/s00726-005-0202-0 DO - 10.1007/s00726-005-0202-0 ID - Pawelke2005 ER - TY - JOUR AU - Malherbe, C. AU - Bidault, R. AU - Netter, C. AU - Guilloteau, D. AU - Vercouillie, J. AU - Arlicot, N. PY - 2019 DA - 2019// TI - Development of a fast and facile analytical approachto quantify radiometabolites in human plasma samples using ultra highperformance liquid chromatography JO - Am J Anal Chem VL - 10 UR - https://doi.org/10.4236/ajac.2019.105016 DO - 10.4236/ajac.2019.105016 ID - Malherbe2019 ER - TY - JOUR AU - Amini, N. AU - Nakao, R. AU - Schou, M. AU - Halldin, C. PY - 2014 DA - 2014// TI - Determination of plasma protein binding of positronemission tomography radioligands by high-performance frontalanalysis JO - J Pharm Biomed Anal VL - 98 UR - https://doi.org/10.1016/j.jpba.2014.05.024 DO - 10.1016/j.jpba.2014.05.024 ID - Amini2014 ER - TY - JOUR AU - Vasdev, N. AU - Collier, T. L. PY - 2016 DA - 2016// TI - Design and prototype of an automatedcolumn-switching HPLC system for radiometabolite analysis JO - Pharmaceuticals (Basel) VL - 9 UR - https://doi.org/10.3390/ph9030051 DO - 10.3390/ph9030051 ID - Vasdev2016 ER - TY - JOUR AU - Kenk, M. AU - Greene, M. AU - Lortie, M. AU - DeKemp, R. A. AU - Beanlands, R. S. AU - DaSilva, J. N. PY - 2008 DA - 2008// TI - Use of a column-switching high-performance liquidchromatography method to assess the presence of specific binding of (R)-and(S)-[11C] rolipram and their labeled metabolites to the phosphodiesterase-4enzyme in rat plasma and tissues JO - Nucl Med Biol VL - 35 ID - Kenk2008 ER - TY - JOUR AU - Hilton, J. AU - Yokoi, F. AU - Dannals, R. F. AU - Ravert, H. T. AU - Szabo, Z. AU - Wong, D. F. PY - 2000 DA - 2000// TI - Column-switching HPLC for the analysis of plasma inPET imaging studies JO - Nucl Med Biol VL - 27 UR - https://doi.org/10.1016/s0969-8051(00)00125-6 DO - 10.1016/s0969-8051(00)00125-6 ID - Hilton2000 ER - TY - JOUR AU - Nakao, R. AU - Halldin, C. PY - 2013 DA - 2013// TI - “Mixed” anionic and non-ionic micellar liquidchromatography for high-speed radiometabolite analysis of positron emissiontomography radioligands JO - J Chromatogr A VL - 1281 ID - Nakao2013 ER - TY - JOUR AU - Farde, L. AU - Eriksson, L. AU - Blomquist, G. AU - Halldin, C. PY - 1989 DA - 1989// TI - Kinetic analysis of central [11C] raclopride bindingto D2-dopamine receptors studied by PET—a comparison to the equilibriumanalysis JO - J Cereb Blood Flow Metab VL - 9 ID - Farde1989 ER - TY - JOUR AU - Hashimoto, H. AU - Kawamura, K. AU - Takei, M. AU - Igarashi, N. AU - Fujishiro, T. AU - Shiomi, S. PY - 2015 DA - 2015// TI - Identification of a major radiometabolite of[11C]PBB3 JO - Nucl Med Biol VL - 42 UR - https://doi.org/10.1016/j.nucmedbio.2015.08.006 DO - 10.1016/j.nucmedbio.2015.08.006 ID - Hashimoto2015 ER - TY - JOUR AU - Maruyama, M. AU - Shimada, H. AU - Suhara, T. AU - Shinotoh, H. AU - Ji, B. AU - Maeda, J. PY - 2013 DA - 2013// TI - Imaging of tau pathology in a tauopathy mouse modeland in Alzheimer patients compared to normal controls JO - Neuron. VL - 79 UR - https://doi.org/10.1016/j.neuron.2013.07.037 DO - 10.1016/j.neuron.2013.07.037 ID - Maruyama2013 ER - TY - JOUR AU - Wood, H. PY - 2013 DA - 2013// TI - Alzheimer disease:[11 C] PBB3—a new PET ligand thatidentifies tau pathology in the brains of patients with AD JO - Nat Rev Neurol VL - 9 ID - Wood2013 ER - TY - JOUR AU - Hashimoto, H. AU - Kawamura, K. AU - Igarashi, N. AU - Takei, M. AU - Fujishiro, T. AU - Aihara, Y. PY - 2014 DA - 2014// TI - Radiosynthesis, photoisomerization, biodistribution,and metabolite analysis of 11C-PBB3 as a clinically useful PET probe forimaging of tau pathology JO - J Nucl Med VL - 55 ID - Hashimoto2014 ER - TY - JOUR AU - Brandon, E. F. AU - Raap, C. D. AU - Meijerman, I. AU - Beijnen, J. H. AU - Schellens, J. H. PY - 2003 DA - 2003// TI - An update on in vitro test methods in human hepaticdrug biotransformation research: pros and cons JO - Toxicol Appl Pharmacol VL - 189 UR - https://doi.org/10.1016/s0041-008x(03)00128-5 DO - 10.1016/s0041-008x(03)00128-5 ID - Brandon2003 ER - TY - JOUR AU - Xu, C. AU - Li, C. Y. AU - Kong, A. N. PY - 2005 DA - 2005// TI - Induction of phase I, II and III drugmetabolism/transport by xenobiotics JO - Arch Pharm Res VL - 28 UR - https://doi.org/10.1007/BF02977789 DO - 10.1007/BF02977789 ID - Xu2005 ER - TY - JOUR AU - Amini, N. AU - Nakao, R. AU - Schou, M. AU - Halldin, C. PY - 2013 DA - 2013// TI - Identification of PET radiometabolites by cytochromeP450, UHPLC/Q-ToF-MS and fast radio-LC: applied to the PET radioligands [11C] flumazenil,[18 F] FE-PE2I, and [11 C] PBR28 JO - Anal Bioanal Chem VL - 405 ID - Amini2013 ER - TY - JOUR AU - Levêque, P. AU - Labar, D. AU - Hoffmann, E. B. PY - 2001 DA - 2001// TI - Gallez Assesment of [18F]-fluoroethylflumazenilmetabolites using HPLC and tandem mass spectrometry JO - J Chromatogr B VL - 754 ID - Levêque2001 ER - TY - JOUR AU - Halldin, C. AU - Stone-Elander, S. AU - Thorell, J. -. O. AU - Persson, A. AU - Sedvall, G. PY - 1988 DA - 1988// TI - 11C-labelling of Ro 15-1788 in two differentpositions, and also 11C-labelling of its main metabolite Ro 15-3890, for PETstudies of benzodiazepine receptors JO - Int J Rad Appl Inst Part A Appl Rad Isotopes VL - 39 ID - Halldin1988 ER - TY - JOUR AU - Persson, A. AU - Pauli, S. AU - Swahn, C. AU - Halldin, C. AU - Sedvall, G. PY - 1989 DA - 1989// TI - Cerebral uptake of 11C—Ro 15—1788 and its acidmetabolite 11C—Ro 15—3890; PET study in healthy volunteers JO - Hum Psychopharmacol Clin Exp VL - 4 ID - Persson1989 ER - TY - JOUR AU - Swahn, C. G. AU - Persson, A. AU - Pauli, S. PY - 1989 DA - 1989// TI - Metabolism of the benzodiazepine antagonist 11C-Ro15-1788 after intravenous administration in man JO - Hum Psychopharmacol Clin Exp VL - 4 ID - Swahn1989 ER - TY - JOUR AU - Debruyne, D. AU - Abadie, P. AU - Barre, L. AU - Albessard, F. AU - Moulin, M. AU - Zarlfian, E. PY - 1991 DA - 1991// TI - Plasma pharmacokinetics and metabolism of thebenzodiazepine antagonist [11 C] Ro 15-1788 (flumazenil) in baboon and humanduring positron emission tomography studies JO - Eur J Drug Metab Pharmacokinet VL - 16 ID - Debruyne1991 ER - TY - JOUR AU - Persson, A. AU - Pauli, S. AU - Swahn, C. G. AU - Halldin, C. AU - Sedvall, G. PY - 1989 DA - 1989// TI - Cerebral uptake of11C?Ro 15?1788 and its acidmetabolite11C?Ro 15?3890; PET study in healthy volunteers JO - Hum Psychopharmacol Clin Exp VL - 4 UR - https://doi.org/10.1002/hup.470040307 DO - 10.1002/hup.470040307 ID - Persson1989 ER - TY - JOUR AU - Briard, E. AU - Zoghbi, S. S. AU - Imaizumi, M. AU - Gourley, J. P. AU - Shetty, H. U. AU - Hong, J. PY - 2008 DA - 2008// TI - Synthesis and evaluation in monkey of two sensitive11C-labeled aryloxyanilide ligands for imaging brain peripheralbenzodiazepine receptors in vivo JO - J Med Chem VL - 51 UR - https://doi.org/10.1021/jm0707370 DO - 10.1021/jm0707370 ID - Briard2008 ER - TY - JOUR AU - Schou, M. AU - Steiger, C. AU - Varrone, A. AU - Guilloteau, D. AU - Halldin, C. PY - 2009 DA - 2009// TI - Synthesis, radiolabeling and preliminary in vivoevaluation of [18F]FE-PE2I, a new probe for the dopaminetransporter JO - Bioorg Med Chem Lett VL - 19 UR - https://doi.org/10.1016/j.bmcl.2009.06.032 DO - 10.1016/j.bmcl.2009.06.032 ID - Schou2009 ER - TY - JOUR AU - Varrone, A. AU - Steiger, C. AU - Schou, M. AU - Takano, A. AU - Finnema, S. J. AU - Guilloteau, D. PY - 2009 DA - 2009// TI - In vitro autoradiography and in vivo evaluation incynomolgus monkey of [18F]FE-PE2I, a new dopamine transporter PETradioligand JO - Synapse. VL - 63 UR - https://doi.org/10.1002/syn.20670 DO - 10.1002/syn.20670 ID - Varrone2009 ER - TY - JOUR AU - Varrone, A. AU - Toth, M. AU - Steiger, C. AU - Takano, A. AU - Guilloteau, D. AU - Ichise, M. PY - 2011 DA - 2011// TI - Kinetic analysis and quantification of the dopaminetransporter in the nonhuman primate brain with 11C-PE2I and18F-FE-PE2I JO - J Nucl Med VL - 52 UR - https://doi.org/10.2967/jnumed.110.077651 DO - 10.2967/jnumed.110.077651 ID - Varrone2011 ER - TY - JOUR AU - Somers, G. I. AU - Harris, A. J. AU - Bayliss, M. K. AU - Houston, J. B. PY - 2007 DA - 2007// TI - The metabolism of the 5HT3 antagonists ondansetron,alosetron and GR87442 I: a comparison of in vitro and in vivo metabolism andin vitro enzyme kinetics in rat, dog and human hepatocytes, microsomes andrecombinant human enzymes JO - Xenobiotica. VL - 37 UR - https://doi.org/10.1080/00498250701485575 DO - 10.1080/00498250701485575 ID - Somers2007 ER - TY - JOUR AU - Graaf, I. A. AU - Meijeren, C. E. AU - Pektas, F. AU - Koster, H. J. PY - 2002 DA - 2002// TI - Comparison of in vitro preparations forsemi-quantitative prediction of in vivo drug metabolism JO - Drug Metab Dispos VL - 30 UR - https://doi.org/10.1124/dmd.30.10.1129 DO - 10.1124/dmd.30.10.1129 ID - Graaf2002 ER - TY - JOUR AU - Halldin, C. AU - Lundberg, J. AU - Sóvágó, J. AU - Gulyás, B. AU - Guilloteau, D. AU - Vercouillie, J. PY - 2005 DA - 2005// TI - [11C] MADAM, a new serotonin transporter radioligandcharacterized in the monkey brain by PET JO - Synapse VL - 58 ID - Halldin2005 ER - TY - JOUR AU - Lundberg, J. AU - Odano, I. AU - Olsson, H. AU - Halldin, C. AU - Farde, L. PY - 2005 DA - 2005// TI - Quantification of 11C-MADAM binding to the serotonintransporter in the human brain JO - J Nucl Med VL - 46 ID - Lundberg2005 ER - TY - JOUR AU - Gourand, F. AU - Amini, N. AU - Jia, Z. AU - Stone-Elander, S. AU - Guilloteau, D. AU - Barré, L. PY - 2015 DA - 2015// TI - [11C] MADAM used as a model for understanding theradiometabolism of diphenyl sulfide radioligands for positron emissiontomography (PET) JO - PLoS One VL - 10 ID - Gourand2015 ER - TY - JOUR AU - Smits, R. AU - Fischer, S. AU - Hiller, A. AU - Deuther-Conrad, W. AU - Wenzel, B. AU - Patt, M. PY - 2014 DA - 2014// TI - Synthesis and biological evaluation of bothenantiomers of [18F] flubatine, promising radiotracers with fast kineticsfor the imaging of α4β2-nicotinic acetylcholine receptors JO - Bioorg Med Chem VL - 22 ID - Smits2014 ER - TY - JOUR AU - Ludwig, F. A. AU - Fischer, S. AU - Smits, R. AU - Deuther-Conrad, W. AU - Hoepping, A. AU - Tiepolt, S. PY - 2018 DA - 2018// TI - Exploring the metabolism of (+)-[(18)F]Flubatine invitro and in vivo: LC-MS/MS aided identification of radiometabolites in aclinical PET study JO - Molecules. VL - 23 UR - https://doi.org/10.3390/molecules23020464 DO - 10.3390/molecules23020464 ID - Ludwig2018 ER - TY - JOUR AU - Patt, M. AU - Becker, G. A. AU - Grossmann, U. AU - Habermann, B. AU - Schildan, A. AU - Wilke, S. PY - 2014 DA - 2014// TI - Evaluation of metabolism, plasma protein binding andother biological parameters after administration of (-)-[(18)F]Flubatine inhumans JO - Nucl Med Biol VL - 41 UR - https://doi.org/10.1016/j.nucmedbio.2014.03.018 DO - 10.1016/j.nucmedbio.2014.03.018 ID - Patt2014 ER - TY - JOUR AU - Hillmer, A. T. AU - Esterlis, I. AU - Gallezot, J. -. D. AU - Bois, F. AU - Zheng, M. -. Q. AU - Nabulsi, N. PY - 2016 DA - 2016// TI - Imaging of cerebral α4β2* nicotinic acetylcholinereceptors with (−)-[18F] Flubatine PET: Implementation of bolus plusconstant infusion and sensitivity to acetylcholine in humanbrain JO - NeuroImage. VL - 141 ID - Hillmer2016 ER - TY - JOUR AU - Ludwig, F. -. A. AU - Smits, R. AU - Fischer, S. AU - Donat, C. AU - Hoepping, A. AU - Brust, P. PY - 2016 DA - 2016// TI - LC-MS supported studies on the in vitro metabolismof both enantiomers of flubatine and the in vivo metabolism of (+)-[18F]flubatine—a positron emission tomography radioligand for imaging α4β2nicotinic acetylcholine receptors JO - Molecules. VL - 21 ID - Ludwig2016 ER - TY - JOUR AU - Brust, P. AU - Patt, J. T. AU - Deuther-Conrad, W. AU - Becker, G. AU - Patt, M. AU - Schildan, A. PY - 2008 DA - 2008// TI - In vivo measurement of nicotinic acetylcholinereceptors with [18F]norchloro-fluoro-homoepibatidine JO - Synapse. VL - 62 UR - https://doi.org/10.1002/syn.20480 DO - 10.1002/syn.20480 ID - Brust2008 ER - TY - JOUR AU - Gallezot, J. D. AU - Esterlis, I. AU - Bois, F. AU - Zheng, M. Q. AU - Lin, S. F. AU - Kloczynski, T. PY - 2014 DA - 2014// TI - Evaluation of the sensitivity of the novel α4β2*nicotinic acetylcholine receptor PET radioligand 18F-(-)-NCFHEB to increasesin synaptic acetylcholine levels in rhesus monkeys JO - Synapse. VL - 68 ID - Gallezot2014 ER - TY - JOUR AU - Bois, F. AU - Gallezot, J. -. D. AU - Zheng, M. -. Q. AU - Lin, S. -. F. AU - Esterlis, I. AU - Cosgrove, K. P. PY - 2015 DA - 2015// TI - Evaluation of[18F]-(-)-norchlorofluorohomoepibatidine ([18F]-(-)-NCFHEB) as a PETradioligand to image the nicotinic acetylcholine receptors in non-humanprimates JO - Nucl Med Biol VL - 42 ID - Bois2015 ER - TY - JOUR AU - Sabri, O. AU - Becker, G. -. A. AU - Meyer, P. M. AU - Hesse, S. AU - Wilke, S. AU - Graef, S. PY - 2015 DA - 2015// TI - First-in-human PET quantification study of cerebralα4β2* nicotinic acetylcholine receptors using the novel specific radioligand(−)-[18F] Flubatine JO - Neuroimage. VL - 118 ID - Sabri2015 ER - TY - JOUR AU - Hara, T. AU - Kosaka, N. AU - Kishi, H. PY - 1998 DA - 1998// TI - PET imaging of prostate cancer usingcarbon-11-choline JO - J Nucl Med VL - 39 ID - Hara1998 ER - TY - JOUR AU - Hara, T. AU - Kosaka, N. AU - Shinoura, N. AU - Kondo, T. PY - 1997 DA - 1997// TI - PET imaging of brain tumor with[methyl-11C]choline JO - J Nucl Med VL - 38 ID - Hara1997 ER - TY - JOUR AU - Smith, G. AU - Zhao, Y. AU - Leyton, J. AU - Shan, B. AU - Perumal, M. AU - Turton, D. PY - 2011 DA - 2011// TI - Radiosynthesis and pre-clinical evaluation of [18F]fluoro-[1, 2-2H4] choline JO - Nucl Med Biol VL - 38 ID - Smith2011 ER - TY - JOUR AU - Schou, M. AU - Halldin, C. AU - Sovago, J. AU - Pike, V. W. AU - Gulyas, B. AU - Mozley, P. D. PY - 2003 DA - 2003// TI - Specific in vivo binding to the norepinephrinetransporter demonstrated with the PET radioligand,(S,S)-[11C]MeNER JO - Nucl Med Biol VL - 30 UR - https://doi.org/10.1016/s0969-8051(03)00079-9 DO - 10.1016/s0969-8051(03)00079-9 ID - Schou2003 ER - TY - JOUR AU - Schou, M. AU - Halldin, C. AU - Sóvágó, J. AU - Pike, V. W. AU - Hall, H. AU - Gulyás, B. PY - 2004 DA - 2004// TI - PET evaluation of novel radiofluorinated reboxetineanalogs as norepinephrine transporter probes in the monkeybrain JO - Synapse. VL - 53 ID - Schou2004 ER - TY - JOUR AU - Terry, G. E. AU - Liow, J. -. S. AU - Zoghbi, S. S. AU - Hirvonen, J. AU - Farris, A. G. AU - Lerner, A. PY - 2009 DA - 2009// TI - Quantitation of cannabinoid CB1 receptors in healthyhuman brain using positron emission tomography and an inverse agonistradioligand JO - Neuroimage. VL - 48 ID - Terry2009 ER - TY - JOUR AU - Terry, G. E. AU - Hirvonen, J. AU - Liow, J. -. S. AU - Zoghbi, S. S. AU - Gladding, R. AU - Tauscher, J. T. PY - 2010 DA - 2010// TI - Imaging and quantitation of cannabinoid CB1receptors in human and monkey brains using 18F-labeled inverse agonistradioligands JO - J Nucl Med VL - 51 ID - Terry2010 ER - TY - JOUR AU - Raaphorst, R. M. AU - Luurtsema, G. AU - Schuit, R. C. AU - Kooijman, E. J. M. AU - Elsinga, P. H. AU - Lammertsma, A. A. PY - 2017 DA - 2017// TI - Synthesis and evaluation of new fluorine-18 labeledverapamil analogs to investigate the function of P-glycoprotein in theblood-brain barrier JO - ACS Chem Neurosci VL - 8 UR - https://doi.org/10.1021/acschemneuro.7b00086 DO - 10.1021/acschemneuro.7b00086 ID - Raaphorst2017 ER - TY - JOUR AU - Raaphorst, R. M. AU - Luurtsema, G. AU - Schokker, C. J. AU - Attia, K. A. AU - Schuit, R. C. AU - Elsinga, P. H. PY - 2018 DA - 2018// TI - Improving metabolic stability of fluorine-18 labeledverapamil analogs JO - Nucl Med Biol VL - 64-65 UR - https://doi.org/10.1016/j.nucmedbio.2018.06.009 DO - 10.1016/j.nucmedbio.2018.06.009 ID - Raaphorst2018 ER - TY - JOUR AU - Luurtsema, G. AU - Molthoff, C. F. AU - Schuit, R. C. AU - Windhorst, A. D. AU - Lammertsma, A. A. AU - Franssen, E. J. PY - 2005 DA - 2005// TI - Evaluation of (R)-[11C]verapamil as PET tracer ofP-glycoprotein function in the blood-brain barrier: kinetics and metabolismin the rat JO - Nucl Med Biol VL - 32 UR - https://doi.org/10.1016/j.nucmedbio.2004.06.007 DO - 10.1016/j.nucmedbio.2004.06.007 ID - Luurtsema2005 ER -